Memory Pharmaceuticals Report issue

For profit Phase 2
Founded: Montvale NJ United States (1997)
Status: Acquired by Roche (2008)

Organization Overview

First Clinical Trial
2005
NCT00257673
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Memory Pharmaceuticals Corp